Jubilant HollisterStier General Partnership
$23,800,000.00 CAD
- Program
- SIF Stream2- Growth
- Recipient country
- Canada
- Fiscal year
- 2021-2022
- Agreement period
- September 16, 2021 – March 31, 2026
- Reference
- ic:033-2022-2023-Q4-817399
Published purpose
Expansion of the Montréal manufacturing capacity for COVID-19 vaccines, diverse injectable drugs and therapeutics with innovative state-of-the-art technology, facility expansion and retrofit and equip
In plain English AI-generated
This federal contribution supports the expansion of a Montreal manufacturing facility to increase production capacity for COVID-19 vaccines and other injectable drugs and therapeutics.
Category: Health Primarily funds activity in Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.